A presentation by Australia's Chief Medical Officer, Professor Jim Bishop AO, for the Australiasian college for Emergency Medicine 27th Annual Scientific Meeting - Canberra
Publishing excel charts and power points presentationGisell20
The document shows the results of a student survey about preferred fast food restaurants to have in their school, with 67% preferring Starbucks. It also includes charts displaying median income by education level, operating expenses of the American Red Cross from 1997 to 2006, and weekly running times from a 10-week workout program that saw times decrease from 35.5 minutes to 34 minutes.
Publishing excel charts and power points presentationGisell20
The document shows the results of a student survey about what type of fast food restaurant students would like in their school, with 67% preferring Starbucks. It also includes charts showing running times over 10 weeks that decreased from 35.5 minutes to 34 minutes, and a table comparing study hours to test grades that indicates higher study hours correlated with better grades.
1) The document discusses exporting into the European Union from a governmental perspective, focusing on EU commercial regulations regarding food safety, presentation, labeling, and quotas.
2) It analyzes the wine export situation of small, agriculture-based countries like Romania, Bulgaria, and Hungary in relation to EU quotas over the period of 1995-2004.
3) The use of quotas by the EU is debated, with arguments on both sides as to whether it represents justified protectionism or unnecessary restriction of trade.
This document discusses how organizations can adapt their behavior to safeguard against corporate manslaughter charges by implementing various policies and procedures. It evaluates how to reduce systemic risks through services and process reviews. It also stresses the importance of effective risk management training for all staff and promoting a culture of good management where decisions are implemented through clear policies. Financial constraints require a long term approach to sustain compliance with health and safety regulations.
34-63% of counties have maternal health tracer drugs but 18-39% of child health tracer drugs available
Large disparities in the availability of first line HIV drugs (0-50%)
Kisumu, Kisii, Vihiga, and Siaya consistently top third in drug availability
Transzoia, E-Marakwet, Nandi, Nyeri & T.River bottom
11 maternal health tracer drugs
11 child health tracer drugs
First-line drugs for HIV
ACT, first line treatment for malaria
4FDC, intensive treatment for tuberculosis
Metformin, preferred OGLA treatment for diabetes
The intersection between corporate and clinical governance - implications for...mikaelastafrace
This document discusses the intersection between corporate and clinical governance for health service directors. It provides definitions and examples of both corporate and clinical governance failures in Australia and overseas. Common themes in failures include ineffective adverse event reporting, lack of transparency, weak credentialing and performance review, and poor communication. The document outlines directors' obligations under various laws and frameworks. It emphasizes the importance of information flow, high trust and engagement between directors and executives, and focusing on patient experience in clinical and corporate governance.
Publishing excel charts and power points presentationGisell20
The document shows the results of a student survey about preferred fast food restaurants to have in their school, with 67% preferring Starbucks. It also includes charts displaying median income by education level, operating expenses of the American Red Cross from 1997 to 2006, and weekly running times from a 10-week workout program that saw times decrease from 35.5 minutes to 34 minutes.
Publishing excel charts and power points presentationGisell20
The document shows the results of a student survey about what type of fast food restaurant students would like in their school, with 67% preferring Starbucks. It also includes charts showing running times over 10 weeks that decreased from 35.5 minutes to 34 minutes, and a table comparing study hours to test grades that indicates higher study hours correlated with better grades.
1) The document discusses exporting into the European Union from a governmental perspective, focusing on EU commercial regulations regarding food safety, presentation, labeling, and quotas.
2) It analyzes the wine export situation of small, agriculture-based countries like Romania, Bulgaria, and Hungary in relation to EU quotas over the period of 1995-2004.
3) The use of quotas by the EU is debated, with arguments on both sides as to whether it represents justified protectionism or unnecessary restriction of trade.
This document discusses how organizations can adapt their behavior to safeguard against corporate manslaughter charges by implementing various policies and procedures. It evaluates how to reduce systemic risks through services and process reviews. It also stresses the importance of effective risk management training for all staff and promoting a culture of good management where decisions are implemented through clear policies. Financial constraints require a long term approach to sustain compliance with health and safety regulations.
34-63% of counties have maternal health tracer drugs but 18-39% of child health tracer drugs available
Large disparities in the availability of first line HIV drugs (0-50%)
Kisumu, Kisii, Vihiga, and Siaya consistently top third in drug availability
Transzoia, E-Marakwet, Nandi, Nyeri & T.River bottom
11 maternal health tracer drugs
11 child health tracer drugs
First-line drugs for HIV
ACT, first line treatment for malaria
4FDC, intensive treatment for tuberculosis
Metformin, preferred OGLA treatment for diabetes
The intersection between corporate and clinical governance - implications for...mikaelastafrace
This document discusses the intersection between corporate and clinical governance for health service directors. It provides definitions and examples of both corporate and clinical governance failures in Australia and overseas. Common themes in failures include ineffective adverse event reporting, lack of transparency, weak credentialing and performance review, and poor communication. The document outlines directors' obligations under various laws and frameworks. It emphasizes the importance of information flow, high trust and engagement between directors and executives, and focusing on patient experience in clinical and corporate governance.
In August 2013, USAID supported the Second Annual Round Table on Governance for Health in Low- and Middle-Income Countries (LMICs). The purpose of the round table was to bring thought leaders together to discuss how good governance enables and facilitates better health system performance and outcomes
Join us for a summary of key conclusions from the round table followed by a discussion about new insights into principles and practices of smart governance in the health systems of LMICs.
Clinical governance is a mechanism for healthcare organizations to continuously improve the quality of their services and maintain high clinical care standards. It creates an environment where excellence in care can flourish. Clinical governance aims to ensure accountability in four key areas: variations in professional performance, efficient use of resources, effective management of risks to patients, and high patient satisfaction.
This document outlines the Zuellig Family Foundation's Community Health Partnership Program which aims to improve governance, health systems, and institutions to improve maternal and child health outcomes. The program involves training municipal mayors, health officers, and civic leaders (called "Municipal Health Leaders") to strengthen their understanding of health and initiate local health programs. Selection criteria for participating municipalities include needing improved health outcomes and commitment from local leaders. The program has shown success in reducing maternal mortality ratios in participating municipalities and aims to expand its model through a new partnership with the Department of Health.
Governance & Innovation in the Canadian Health SystemMatthew Lister
The document discusses the role of health system governors in leading innovation, focusing on how governance has influenced massive system change in other industries and the relationship between governance and innovation. It examines how organizations can enable innovation through different governance models such as external oversight, collaborative partnerships, and establishing internal innovation functions.
CLINICAL GOVERNANCE SYSTEMS - AS A TOOL FOR IMPROVING PATIENT SAFETY Ruby Med Plus
This essay explores how Clinical governance as a process is interpreted,
understood and practiced for improving the quality of patient care and Patient
safety.
Specific Objectives-
1. To give an overview of corporate governance and Clinical governance and
to focus on Definition, principles, need, components, key features and
benefits of Clinical governance.
2. To Understand the principles and Pre-requisites of Governance and
clinical governance.
3. To comprehend Power Culture, Quality Assurance, Clinical Audit, and
Clinical Governance.
4. To analyse decision making, safety culture, Integrated pathways,
informed consent, right clinical information, Acrediation and Clinical
Governance.
Clinical Governance Presentation by Michael Gorton AM - 21 July 2016Russell_Kennedy
Clinical governance in the health sector. This presentation covers the issues of liability, accountability, risk management and compliance that all health organisations must address.
This document discusses clinical governance practices regarding primary percutaneous coronary intervention (PPCI) and direct admission of high-risk non-ST-segment elevation myocardial infarction (NSTEMI) patients. It outlines some recurrent issues like monitoring, medications, communication, and delays. It also describes opportunities to learn from past cases without blame. Meeting and feedback structures are in place between teams. Referral processes and decision making are important, and several case studies illustrate lessons learned from reviews of past patient transfers and treatments. Open communication between ambulance and hospital staff is encouraged.
This document discusses human behavior in organizations. It defines human behavior as any conscious or unconscious acts that reflect a person's thoughts, feelings, emotions, and state. Human behavior is influenced by cultural anthropology, psychology, and sociology. Studying human behavior helps understand ourselves and others to improve relationships and organizational productivity. Key variables that affect human behavior in work include work design, performance appraisal, communication, and organizational structure. The document also discusses models of human behavior in organizations and principles like Thorndike's law of effect.
Devolution of health services in Kenya by Dr Samuel Mwenda, CHAKachapkenya
This document discusses the devolution of health services in Kenya following the new constitution of 2010. It summarizes that health services are now managed at the county level while the national government focuses on policy, referral hospitals, and training. It outlines the challenges of transitioning to this new system, including establishing new governance structures and changing the employment of health workers. Faith-based organizations still play an important role in healthcare delivery and need to find ways to engage with each county government to ensure access to resources and their patients' needs are still met under the devolved system.
This document discusses the concept of clinical governance in healthcare. It defines clinical governance as a system through which organizations are accountable for quality improvement and patient safety. The document outlines the Temple Model of Clinical Governance, which includes systems awareness, teamwork, communication, ownership, and leadership as foundational stones. It also discusses the pillars of clinical governance: clinical effectiveness, risk management, patient experiences, learning from complaints, communication effectiveness, resource effectiveness, and strategic effectiveness.
Governance influences all other health system functions, thereby leading to improved performance of the health system and ultimately to better health outcomes.
Defence Health Leadership Institute (DHLI) Panel DiscussionsDepartment of Health
This document discusses health trends and reforms in Australia. It shows that chronic diseases are increasing while some cancers are declining. New structures like Medicare Locals and clinical guidelines aim to improve coordinated, evidence-based care. Reforms also seek to expand the health workforce to strengthen primary care and address workforce shortages.
Amsa annual national leadership development seminar 30 aug 2010Department of Health
The document discusses Australia's health system and outcomes. It shows that while Australia ranks highly for health expenditures and outcomes, challenges remain from non-communicable diseases like cancer, cardiovascular disease, and obesity. It outlines initiatives to address tobacco use, promote healthy living, fund medical research, expand the healthcare workforce, and implement clinical guidelines to improve health and reduce disease burden going forward.
Rafael Matesanz - Spain - Monday 28 - Strategies to increase the number of c...incucai_isodp
The document discusses strategies for increasing deceased organ donation rates around the world. It provides an overview of organ donation rates in different countries and regions, factors that influence donation effectiveness like healthcare structure and population willingness. Benchmarking studies identified best practices for donor detection, management, and obtaining consent from top performing hospitals. Recommendations were developed and guidelines published in multiple languages to spread these practices and help other areas progress toward self-sufficiency in organ transplantation.
The document outlines Spain's National Strategy for Innovation (E2I). It begins with a diagnostic of the Spanish economy, noting declines in R&D spending, unemployment increases especially in construction and industry, and lower outputs in high-tech employment and patents compared to EU averages. The objectives are to boost Spain into the top 9 in GDP and innovation world rankings by 2015 through increasing private R&D investment to 1.9% of GDP, mobilizing €6 billion in private funding, and incorporating 40,000 companies into innovative activities to transition Spain's economy based on science and innovation.
The document outlines the Australian government's new approach to strengthening the aged care complaints scheme. It discusses feedback received from the aged care sector calling for improvements such as local resolution of complaints where possible, expanded resolution options, transparency and accountability, quality and consistency, clear communication, procedural fairness, and continuous engagement with the sector. The presentation notes improvements that should already be seen or are in progress based on this feedback.
The document discusses Australia's health system and reforms. It shows that Australia ranks high for health expenditure per capita compared to other OECD countries, both publicly and privately. Major causes of disease burden are projected to increase, such as cancer and cardiovascular disease. Reforms include establishing Medicare Locals to better coordinate primary care, developing e-health records, and releasing clinical guidelines to improve practices for conditions with high disease burden.
Pandemics: Dealing with the Unexpected "Scientific Theory and Practical Reality"Department of Health
A presentation by Australia's Chief Medical Officer, Professor Jim Bishop AO. Options for the control of Influenza VII Conference - Hong Kong 6 Sept 2010
A presentation by Australia's Chief Medical Officer, Professor Jim Bishop AO,to the PHAA 12th National Immunisation Conference in Adelaide 17 August 2010
In August 2013, USAID supported the Second Annual Round Table on Governance for Health in Low- and Middle-Income Countries (LMICs). The purpose of the round table was to bring thought leaders together to discuss how good governance enables and facilitates better health system performance and outcomes
Join us for a summary of key conclusions from the round table followed by a discussion about new insights into principles and practices of smart governance in the health systems of LMICs.
Clinical governance is a mechanism for healthcare organizations to continuously improve the quality of their services and maintain high clinical care standards. It creates an environment where excellence in care can flourish. Clinical governance aims to ensure accountability in four key areas: variations in professional performance, efficient use of resources, effective management of risks to patients, and high patient satisfaction.
This document outlines the Zuellig Family Foundation's Community Health Partnership Program which aims to improve governance, health systems, and institutions to improve maternal and child health outcomes. The program involves training municipal mayors, health officers, and civic leaders (called "Municipal Health Leaders") to strengthen their understanding of health and initiate local health programs. Selection criteria for participating municipalities include needing improved health outcomes and commitment from local leaders. The program has shown success in reducing maternal mortality ratios in participating municipalities and aims to expand its model through a new partnership with the Department of Health.
Governance & Innovation in the Canadian Health SystemMatthew Lister
The document discusses the role of health system governors in leading innovation, focusing on how governance has influenced massive system change in other industries and the relationship between governance and innovation. It examines how organizations can enable innovation through different governance models such as external oversight, collaborative partnerships, and establishing internal innovation functions.
CLINICAL GOVERNANCE SYSTEMS - AS A TOOL FOR IMPROVING PATIENT SAFETY Ruby Med Plus
This essay explores how Clinical governance as a process is interpreted,
understood and practiced for improving the quality of patient care and Patient
safety.
Specific Objectives-
1. To give an overview of corporate governance and Clinical governance and
to focus on Definition, principles, need, components, key features and
benefits of Clinical governance.
2. To Understand the principles and Pre-requisites of Governance and
clinical governance.
3. To comprehend Power Culture, Quality Assurance, Clinical Audit, and
Clinical Governance.
4. To analyse decision making, safety culture, Integrated pathways,
informed consent, right clinical information, Acrediation and Clinical
Governance.
Clinical Governance Presentation by Michael Gorton AM - 21 July 2016Russell_Kennedy
Clinical governance in the health sector. This presentation covers the issues of liability, accountability, risk management and compliance that all health organisations must address.
This document discusses clinical governance practices regarding primary percutaneous coronary intervention (PPCI) and direct admission of high-risk non-ST-segment elevation myocardial infarction (NSTEMI) patients. It outlines some recurrent issues like monitoring, medications, communication, and delays. It also describes opportunities to learn from past cases without blame. Meeting and feedback structures are in place between teams. Referral processes and decision making are important, and several case studies illustrate lessons learned from reviews of past patient transfers and treatments. Open communication between ambulance and hospital staff is encouraged.
This document discusses human behavior in organizations. It defines human behavior as any conscious or unconscious acts that reflect a person's thoughts, feelings, emotions, and state. Human behavior is influenced by cultural anthropology, psychology, and sociology. Studying human behavior helps understand ourselves and others to improve relationships and organizational productivity. Key variables that affect human behavior in work include work design, performance appraisal, communication, and organizational structure. The document also discusses models of human behavior in organizations and principles like Thorndike's law of effect.
Devolution of health services in Kenya by Dr Samuel Mwenda, CHAKachapkenya
This document discusses the devolution of health services in Kenya following the new constitution of 2010. It summarizes that health services are now managed at the county level while the national government focuses on policy, referral hospitals, and training. It outlines the challenges of transitioning to this new system, including establishing new governance structures and changing the employment of health workers. Faith-based organizations still play an important role in healthcare delivery and need to find ways to engage with each county government to ensure access to resources and their patients' needs are still met under the devolved system.
This document discusses the concept of clinical governance in healthcare. It defines clinical governance as a system through which organizations are accountable for quality improvement and patient safety. The document outlines the Temple Model of Clinical Governance, which includes systems awareness, teamwork, communication, ownership, and leadership as foundational stones. It also discusses the pillars of clinical governance: clinical effectiveness, risk management, patient experiences, learning from complaints, communication effectiveness, resource effectiveness, and strategic effectiveness.
Governance influences all other health system functions, thereby leading to improved performance of the health system and ultimately to better health outcomes.
Defence Health Leadership Institute (DHLI) Panel DiscussionsDepartment of Health
This document discusses health trends and reforms in Australia. It shows that chronic diseases are increasing while some cancers are declining. New structures like Medicare Locals and clinical guidelines aim to improve coordinated, evidence-based care. Reforms also seek to expand the health workforce to strengthen primary care and address workforce shortages.
Amsa annual national leadership development seminar 30 aug 2010Department of Health
The document discusses Australia's health system and outcomes. It shows that while Australia ranks highly for health expenditures and outcomes, challenges remain from non-communicable diseases like cancer, cardiovascular disease, and obesity. It outlines initiatives to address tobacco use, promote healthy living, fund medical research, expand the healthcare workforce, and implement clinical guidelines to improve health and reduce disease burden going forward.
Rafael Matesanz - Spain - Monday 28 - Strategies to increase the number of c...incucai_isodp
The document discusses strategies for increasing deceased organ donation rates around the world. It provides an overview of organ donation rates in different countries and regions, factors that influence donation effectiveness like healthcare structure and population willingness. Benchmarking studies identified best practices for donor detection, management, and obtaining consent from top performing hospitals. Recommendations were developed and guidelines published in multiple languages to spread these practices and help other areas progress toward self-sufficiency in organ transplantation.
The document outlines Spain's National Strategy for Innovation (E2I). It begins with a diagnostic of the Spanish economy, noting declines in R&D spending, unemployment increases especially in construction and industry, and lower outputs in high-tech employment and patents compared to EU averages. The objectives are to boost Spain into the top 9 in GDP and innovation world rankings by 2015 through increasing private R&D investment to 1.9% of GDP, mobilizing €6 billion in private funding, and incorporating 40,000 companies into innovative activities to transition Spain's economy based on science and innovation.
Similar to Clinical Governance and Health Reform (7)
The document outlines the Australian government's new approach to strengthening the aged care complaints scheme. It discusses feedback received from the aged care sector calling for improvements such as local resolution of complaints where possible, expanded resolution options, transparency and accountability, quality and consistency, clear communication, procedural fairness, and continuous engagement with the sector. The presentation notes improvements that should already be seen or are in progress based on this feedback.
The document discusses Australia's health system and reforms. It shows that Australia ranks high for health expenditure per capita compared to other OECD countries, both publicly and privately. Major causes of disease burden are projected to increase, such as cancer and cardiovascular disease. Reforms include establishing Medicare Locals to better coordinate primary care, developing e-health records, and releasing clinical guidelines to improve practices for conditions with high disease burden.
Pandemics: Dealing with the Unexpected "Scientific Theory and Practical Reality"Department of Health
A presentation by Australia's Chief Medical Officer, Professor Jim Bishop AO. Options for the control of Influenza VII Conference - Hong Kong 6 Sept 2010
A presentation by Australia's Chief Medical Officer, Professor Jim Bishop AO,to the PHAA 12th National Immunisation Conference in Adelaide 17 August 2010
This document discusses developments in the health sector and cancer in Australia. It notes that Australia ranks highly among OECD countries for health expenditure per capita and health outcomes. Cancer mortality rates have declined significantly for several types of cancer due to public health measures like tobacco control, screening programs, and improved treatments. However, obesity rates are rising and greater efforts are needed to address risk factors like physical inactivity, diet, and alcohol to further reduce the cancer burden.
A presentation by Australia's Chief Medical Officer, Professor Jim Bishop AO, on Cancer Control in Australia - Institute of Cancer Research 12 July 2010
This document discusses chronic diseases in Australia and reports that:
- Chronic diseases represent the major disease burden in Australia, with conditions like cardiovascular disease, cancer, diabetes and chronic respiratory disease posing significant challenges.
- While tobacco control initiatives have seen smoking rates decline, other determinants of chronic disease like obesity, high blood pressure, and alcohol consumption continue to increase and impact population health.
- The Australian government has implemented initiatives through the National Preventative Health Agency and Australian Health Survey to better understand and address chronic disease, with over $2 billion allocated in 2009/10 for cancer control programs.
This document summarizes information about the 2009 H1N1 influenza pandemic presented by Professor Jim Bishop. It provides an overview of the epidemiology and severity of the 2009 H1N1 virus, its impact on transplant recipients, and the current global situation. Some key points are that the 2009 H1N1 virus resulted in over 37,000 cases and 191 deaths in Australia, with higher rates of hospitalization and ICU admission compared to seasonal influenza. It also resulted in significant illness in transplant recipients, though antiviral treatment reduced complications. Currently, influenza activity is low in both the Northern and Southern Hemispheres.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
1. CLINICAL GOVERNANCE and
HEALTH REFORM
AUSTRALIASIAN COLLEGE FOR EMERGENCY
MEDICINE 27th ANNUAL SCIENTIFIC MEETING
CANBERRA – 23 November 2010
Professor Jim Bishop AO
Chief Medical Officer
Australian Government Department of Health and Ageing
2. OECD HEALTH DATA 2010
How Does AUSTRALIA Compare
Health Expenditure per capita, public and private expenditure, OECD countries, 2008 ($US PPP)
8,000
7538
7,000
6,000
5004
5,000 4627
4210
4079 4063
3970
4,000 3793 3737
3696 3677
3540 3470
3359 3353
3129 3060
3008
2902 2870
3,000 2729 2687 2683
2151
2,000 1801 1781 1737
1437
1213
999
852
1,000 767
0
1 Refers to insured po pulatio n rather than resident po pulatio n. 2. Current expenditure. 3. 2006. 4. 2007. So urce: OECD, OECD Health Data, June 201
. 0
Public expenditure on health Private expenditure on health
15. HEALTH REFORM
Increasing expenditure to $15 billion 2010/11
Additional $7.3 billion over 4 years
Local Hospital Networks (LHN) 60% Federal
Funds (60% of research and teaching)
Medicare locals (100% Federal funds)
GP Super-clinics – multi disciplinary teams
(100% Federal Funds)
16. MEDICARE LOCALS
OBJECTIVES
Identification and response to local
health needs
Integrated and coordinated care for the
patient
Support clinicians to improve care
Implement new primary care initiatives
Accountable for efficiency and quality
17. BUDGET 2010-11
e-Health – connecting patients, providers and information
systems
The Government will establish a personally controlled electronic health
record system ($466.7m)
The system will:
Enable people – and their chosen health provider - to
access online their key health information when and
where it is needed, for their care across the health
system.
Allow people to register online to establish a personally
controlled electronic health record from 2012-13
Rigorous governance
Privacy maintained
18. HEALTH REFORM
KEY NEW STRUCTURES
National Performance Authority
Independent Hospital Pricing Authority
Expanded Australian Commission of
Safety and Quality in Health Care
(ACSQHC)
19. CLINICAL GUIDELINES
SUPPORTS FOR CLINICAL
DECISION MAKING
Evidence Base
Highest Impact
Range of best practice tools
Successful implementation methods
Monitor and report
20. CLINICAL GUIDELINES
Highest Impact
Greatest Burden of disease
Greatest harm from poor practice
Greatest demonstrated need:
- New Standard of Care
- Proven variation in practice
Greatest time spent/cost to health system
21. REVIEW OF CLINICAL GUIDELINES
N – 313
N %
CANCER 17 5%
CARDIOVASCULAR 18 6%
RENAL 22 7%
MENTAL ILLNESS 22 7%
NEUROLOGICAL 0 0%
INJURIES 13 14%
CHRONIC RESPIRATORY 0 0%
DIABETES 11 4%
OTHER 173 67%
TOTAL 313 100%
Buchan et al 2006
22. NON-COMMERCIAL CANCER
RESEARCH EXPENDITURE, 2004
(A$ per CAPITAL)
Source: Eckhouse et al (2007), ABS
26. NHMRC SUPPORT FOR
TRANSLATIONAL RESEARCH
Translational funding mechanisms
Partnership Projects for Better Health
Partnership Centres for Better Health
Centres of Clinical Research Excellence
Centres of Research Excellence in Population Health
Research, & Health Services Research
National Health Research Enabling Capabilities Scheme
Industry Development awards
27. NHMRC PROJECT GRANTS
Clinical Trials Expenditure
$70 300
Millions
$60
250
$50
200
$40
150
$30
100
$20
50
$10
$0 0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Total Expenditure Number of Grants
28. Harmonization of Multi-centred
Ethical Review (HoMER)
National Statement for Ethical Conduct of Human
Research (2007)
Process supported by AHMAC conducted by
NHMRC
Certification of ethical review processes – first
round
Roles, responsibilities, templates published
NHMRC working with States and Territories
29. HEALTH WORKFORCE
Established Health Workforce Australia
$1.2 billion in training more GPs and specialists,
nurses and allied health
1375 more GPs by 2013, 5500 by 2020
680 more specialists by 2020
4600 practice nurses by 2013, 7500 rural nurses by
2020
31. CONCLUSIONS
Increasing burden of chronic diseases especially cancer,
dementia and diabetes
New reform structures offer opportunities to set new
clinical guidelines and standards
Opportunities for more coordinated care through
medicare locals, local hospital networks and lead
clinician groups
Increased health workforce provides opportunities for
greater depth in general practice and in specialist
training
Increased need for greater evidence base as a framework
for improved guidelines and decision tools